文献速递治疗药物监测与药物基因组学特殊人群用药

模型引导精准给药的持续学习:儿童万古霉素给药案例研究

Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin.
PubMed 文献 · Clin Pharmacol Ther · 2020-11-21

该研究在273例儿科ICU患者中评估5个已发表万古霉素群体药动学模型的性能,并模拟自动化持续学习流程,用50-350例患者拟合两个预设简单模型。持续学习模型相比已发表模型可降低预测误差2-13%,至少200例患者可捕获个体间变异,稀疏常规血药浓度数据可合理估计模拟AUC。

要点

  • 已发表万古霉素模型在273例儿科ICU患者中表现充分。
  • 持续学习模型较已发表模型降低预测误差2-13%。
  • 至少200例患者可捕获本院万古霉素个体间变异。

核心结论

  • 在儿科万古霉素MIPD中,持续学习策略相比已发表模型可降低预测误差2-13%。
  • 基于稀疏常规临床数据可持续更新模型,为持续学习MIPD奠定基础。

研究设计与样本

  • 案例研究:评估5个已发表模型在273例儿科ICU患者数据集中的性能。
  • 在两个50-350例患者人群中拟合两个预设简单PK模型,模拟自动化持续学习。

主要发现

  • 5个已发表模型在273例儿科ICU患者中表现充分。
  • 持续学习模型使用群体PK参数时预测误差较已发表模型降低2-13%。
  • 至少200例患者适合捕获该机构万古霉素个体间变异,更大数据集获益有限。
  • 以谷浓度为主的稀疏常规临床数据可合理估计模拟AUC。

临床怎么用

  • 可基于本院常规稀疏血药浓度数据持续更新万古霉素PK模型以支持儿科MIPD。
  • 本院建模样本量至少200例即可捕获个体间变异,无需盲目扩大数据集。

局限性

  • 数据以谷浓度样本为主,采样稀疏。
  • 持续学习模拟基于两个预设简单PK模型,非真实临床部署验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Model-informed precision dosing (MIPD) leverages pharmacokinetic (PK) models to tailor dosing to an individual patient's needs, improving attainment of therapeutic drug exposure targets and thus potentially improving drug efficacy or reducing adverse events. However, selection of an appropriate model for supporting clinical decision making is not trivial. Error or bias in dose selection may arise if the selected model was developed in a population not fully representative of the intended MIPD population. One previously proposed approach is continuous learning, in which an initial model is used in MIPD and then updated as additional data becomes available. In this case study of pediatric vancomycin MIPD, the potential benefits of the continuous learning approach are investigated. Five previously published models were evaluated and found to perform adequately in a data set of 273 pediatric patients in the intensive care unit. Additionally, two predefined simple PK models were fitted on separate populations of 50-350 patients in an approach mimicking clinical implementation of automated continuous learning. With these continuous learning models, prediction error using population PK parameters could be reduced by 2-13% compared with previously published models. Sample sizes of at least 200 patients were found suitable for capturing the interindividual variability in vancomycin at this institution, with limited benefits of larger data sets. Although comprised mostly of trough samples, these sparsely sampled routine clinical data allowed for reasonable estimation of simulated area under the curve (AUC). Together, these findings lay the foundations for a continuous learning MIPD approach.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Hughes JH, Tong DMH, Lucas SS, et al. Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin. Clin Pharmacol Ther. 2020. PMID: 33068298. doi:10.1002/cpt.2088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。